title: Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment.
abstract: Cancer is generally characterized by loss of CG dinucleotides methylation resulting in a global hypomethylation and the consequent genomic instability. The major contribution to the general decreased methylation levels seems to be due to demethylation of heterochromatin repetitive DNA sequences. In human immunodeficiency, centromeric instability and facial anomalies syndrome, demethylation of pericentromeric satellite 2 DNA sequences has been correlated to functional mutations of the de novo DNA methyltransferase 3b (DNMT3b), but the mechanism responsible for the hypomethylated status in tumors is poorly known. Here, we report that human glioblastoma is affected by strong hypomethylation of satellite 2 pericentromeric sequences that involves the stem cell compartment. Concomitantly with the integrity of the DNMTs coding sequences, we report aberrations in DNA methyltrasferases expression showing upregulation of the DNA methyltransferase 1 (DNMT1) and downregulation of the de novo DNA methyltransferase 3a (DNMT3a). Moreover, we show that DNMT3a is the major de novo methyltransferase expressed in normal neural progenitor cells (NPCs) and its forced re-expression is sufficient to partially recover the methylation levels of satellite 2 repeats in glioblastoma cell lines. Thus, we speculate that DNMT3a decreased expression may be involved in the early post-natal inheritance of an epigenetically altered NPC population that could be responsible for glioblastoma development later in adult life.
authors.affiliation: Centre of Biotechnology, University of Urbino, Fano, Italy. mirco.fanelli@uniurb.it
authors.forename: M
authors.initials: M
authors.lastname: Fanelli
authors.forename: S
authors.initials: S
authors.lastname: Caprodossi
authors.forename: L
authors.initials: L
authors.lastname: Ricci-Vitiani
authors.forename: A
authors.initials: A
authors.lastname: Porcellini
authors.forename: F
authors.initials: F
authors.lastname: Tomassoni-Ardori
authors.forename: S
authors.initials: S
authors.lastname: Amatori
authors.forename: F
authors.initials: F
authors.lastname: Andreoni
authors.forename: M
authors.initials: M
authors.lastname: Magnani
authors.forename: R
authors.initials: R
authors.lastname: De Maria
authors.forename: A
authors.initials: A
authors.lastname: Santoni
authors.forename: S
authors.initials: S
authors.lastname: Minucci
authors.forename: P G
authors.initials: PG
authors.lastname: Pelicci
mesh_terms: D001932:Brain Neoplasms / Q000201:enzymology / Q000235:genetics*; D045744:Cell Line, Tumor; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics / Q000378:metabolism*; D019175:DNA Methylation; D000090205:DNA Methyltransferase 3A; D004276:DNA, Satellite / Q000378:metabolism; D044127:Epigenesis, Genetic; D005909:Glioblastoma / Q000201:enzymology / Q000235:genetics*; D006801:Humans; D014411:Neoplastic Stem Cells / Q000201:enzymology*; D009474:Neurons / Q000201:enzymology
chemical_list: D004276:DNA, Satellite; C000717967:DNMT3A protein, human; D004248:DNA (Cytosine-5-)-Methyltransferases; D000090205:DNA Methyltransferase 3A